Zy Therapeutics is pleased to announce its participation in the International Conference on Tuberous Sclerosis Complex and Related Neurocutaneous Disorders, taking place May 21–23, 2026 in Warsaw, Poland.
This meeting brings together leading clinicians, researchers, and patient-focused experts dedicated to advancing understanding and treatment of TSC and related conditions, including Sturge–Weber Syndrome.
Building on a successful Scientific Advisory Board held at AES 2025, Zy Therapeutics continues to advance KaminiTM, a program designed as a potential disease-modifying approach targeting pathological calcium accumulation in the central nervous system.
The Warsaw meeting represents an important opportunity to:
- Engage with global centers of excellence in neurocutaneous disorders
- Discuss clinical development strategies in rare neurological disease
- Explore collaborations within the international research and advocacy community
Zy Therapeutics welcomes the opportunity to connect with clinicians, researchers, and potential partners during the meeting.
For more information on the conference, please visit:
https://tsc.viamedica.pl/51810.1.2026.warszawa
